International Journal of Biological Sciences · 2020 · 41 citations · 32 references
MedicineOncologyPharmacologyBreast OncologyCancer PharmacologyMolecular OncologyBreast Cancer PharmacotherapyCancer ChemopreventionHer2-positive Breast CancerOncology PharmacologyAmp-activated Protein Kinase InteractionAnticancer ActivityC-myc RegulationCancer Cell Proliferation InhibitionCell Growth RegulationHer2-positive Breast Cancer TherapyLipid Metabolism EffectsLipid Metabolism Pathways
Various clinical studies have determined that aspirin shows anticancer effects in many human malignant cancers, including human epidermal growth factor receptor-2 (HER-2)-positive breast cancer. However, the anti-tumor mechanism of aspirin has not been fully defined. The aim of this study was to determine the role of Compound C in enhancing the anticancer effect of aspirin. HER-2-positive breast cancer cell lines were treated with aspirin with or without Compound C pre-treatment; their phenotypes and mechanisms were then analyzed in vitro and in vivo. Aspirin exhibited anticancer effects in HER-2-positive breast cancer by inhibiting cell growth and inducing apoptosis through the activation of AMP-activated protein kinase (AMPK). Unexpectedly, pre-treatment with Compound C, a widely used AMPK inhibitor, induced robust anticancer effects in cells compared to aspirin monotherapy. This anticancer effect was not distinct in HER-2 negative breast cancer MDA-MB-231 cells and may be due to the inhibition of lipid metabolism mediated by c-myc. Besides, c-myc re-expression or palmitic acid supply could partially restored cell proliferation. Aspirin exhibits anticancer effects in HER-2-positive breast cancer by regulating lipid metabolism mediated by c-myc, and Compound C strengthens these effects in an AMPK-independent manner. Our results potentially provide a novel therapeutic strategy exploiting combined aspirin and Compound C therapy for HER-2-positive breast cancer, which acts by reducing de novo lipid synthesis.
32
Rebecca L. Siegel, Jiemin Ma, Zhaohui Zou et al. · CA A Cancer Journal for Clinicians · 2014 · 11.6K citations · Full text
MYC, Metabolism, Cell Growth, and Tumorigenesis
Chi V. Dang · Cold Spring Harbor Perspectives in Medicine · 2013 · 602 citations · Full text
Medicine, Cancer Biology, Oncology +17
Distinct Thresholds Govern Myc's Biological Output In Vivo
Daniel J. Murphy, Melissa R. Junttila, Laurent Pouyet et al. · Cancer Cell · 2008 · 461 citations · Full text